CN110068645A - 液质联用检测尿液中环磷酸腺苷的方法 - Google Patents
液质联用检测尿液中环磷酸腺苷的方法 Download PDFInfo
- Publication number
- CN110068645A CN110068645A CN201910265327.4A CN201910265327A CN110068645A CN 110068645 A CN110068645 A CN 110068645A CN 201910265327 A CN201910265327 A CN 201910265327A CN 110068645 A CN110068645 A CN 110068645A
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- camp
- volume
- solution
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 50
- 210000002700 urine Anatomy 0.000 title claims abstract description 45
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 title claims abstract description 15
- 239000012071 phase Substances 0.000 claims abstract description 80
- 238000001514 detection method Methods 0.000 claims abstract description 31
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 18
- 239000012085 test solution Substances 0.000 claims abstract description 13
- 238000005349 anion exchange Methods 0.000 claims abstract description 12
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 12
- 238000010828 elution Methods 0.000 claims abstract description 10
- 238000002203 pretreatment Methods 0.000 claims abstract description 9
- 238000012544 monitoring process Methods 0.000 claims abstract description 8
- 239000007921 spray Substances 0.000 claims abstract description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- 150000002500 ions Chemical class 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 25
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 7
- 239000005695 Ammonium acetate Substances 0.000 claims description 7
- 235000019257 ammonium acetate Nutrition 0.000 claims description 7
- 229940043376 ammonium acetate Drugs 0.000 claims description 7
- 239000012086 standard solution Substances 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 6
- 239000013558 reference substance Substances 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 235000011056 potassium acetate Nutrition 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- 238000012360 testing method Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000012417 linear regression Methods 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 6
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 230000002349 favourable effect Effects 0.000 abstract description 3
- 238000002552 multiple reaction monitoring Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 21
- 238000005259 measurement Methods 0.000 description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 230000009514 concussion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- WUPZNKGVDMHMBS-UHFFFAOYSA-N azane;dihydrate Chemical compound [NH4+].[NH4+].[OH-].[OH-] WUPZNKGVDMHMBS-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000013062 quality control Sample Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910265327.4A CN110068645B (zh) | 2019-04-03 | 2019-04-03 | 液质联用检测尿液中环磷酸腺苷的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910265327.4A CN110068645B (zh) | 2019-04-03 | 2019-04-03 | 液质联用检测尿液中环磷酸腺苷的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110068645A true CN110068645A (zh) | 2019-07-30 |
CN110068645B CN110068645B (zh) | 2021-09-03 |
Family
ID=67366929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910265327.4A Active CN110068645B (zh) | 2019-04-03 | 2019-04-03 | 液质联用检测尿液中环磷酸腺苷的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110068645B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112964818A (zh) * | 2021-02-05 | 2021-06-15 | 山东省产品质量检验研究院 | 一种检测化妆品中环磷酸腺苷的方法 |
CN116735772A (zh) * | 2023-08-16 | 2023-09-12 | 天津医科大学总医院 | 一种用于尿液分析的腺苷含量检测方法及系统 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1199338A (zh) * | 1995-08-18 | 1998-11-18 | 普渡研究基金会 | 作为多巴胺受体的配体的新的稠合异喹啉 |
CN104198617A (zh) * | 2014-09-18 | 2014-12-10 | 宁夏大学 | 同时测定小柴胡颗粒中环磷酸腺苷、黄芩苷和甘草酸含量的方法 |
CN105228521A (zh) * | 2013-01-31 | 2016-01-06 | 布雷恩勒布斯有限公司 | 诊断抑郁症和监控治疗效果的新的诊断方法 |
CN108152387A (zh) * | 2017-11-22 | 2018-06-12 | 新疆农垦科学院 | 一种红枣中环磷酸腺苷的分析方法 |
-
2019
- 2019-04-03 CN CN201910265327.4A patent/CN110068645B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1199338A (zh) * | 1995-08-18 | 1998-11-18 | 普渡研究基金会 | 作为多巴胺受体的配体的新的稠合异喹啉 |
CN105228521A (zh) * | 2013-01-31 | 2016-01-06 | 布雷恩勒布斯有限公司 | 诊断抑郁症和监控治疗效果的新的诊断方法 |
CN104198617A (zh) * | 2014-09-18 | 2014-12-10 | 宁夏大学 | 同时测定小柴胡颗粒中环磷酸腺苷、黄芩苷和甘草酸含量的方法 |
CN108152387A (zh) * | 2017-11-22 | 2018-06-12 | 新疆农垦科学院 | 一种红枣中环磷酸腺苷的分析方法 |
Non-Patent Citations (3)
Title |
---|
JAN-OLOF SVENSSON等: "Determination of adenosine and cyclic adenosine monophosphate in urine using solid-phase extraction and high-performance liquid chromatography with fluorimetric detection", 《JOURNAL OF CHROMATOGRAPHY》 * |
PIEC I等: "A LC-MS/MS method for the diagnostic measurement of cAMP in plasma and urine", 《JOURNAL OF BONE AND MINERAL RESEARCH》 * |
THOMAS VAN DAMME等: "Determination of cyclic guanosine- and cyclic adenosine monophosphate (cGMP and cAMP) in human plasma and animal tissues by solid phase extraction on silica and liquid chromatography–triple quadrupole mass spectrometry", 《JOURNAL OF CHROMATOGRAPHY B》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112964818A (zh) * | 2021-02-05 | 2021-06-15 | 山东省产品质量检验研究院 | 一种检测化妆品中环磷酸腺苷的方法 |
CN116735772A (zh) * | 2023-08-16 | 2023-09-12 | 天津医科大学总医院 | 一种用于尿液分析的腺苷含量检测方法及系统 |
CN116735772B (zh) * | 2023-08-16 | 2023-10-24 | 天津医科大学总医院 | 一种用于尿液分析的腺苷含量检测方法及系统 |
Also Published As
Publication number | Publication date |
---|---|
CN110068645B (zh) | 2021-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107449841A (zh) | 一种基于衍生化测定单胺类神经递质的检测方法 | |
CN105510480A (zh) | 烘焙食品中2-甲基咪唑和4-甲基咪唑的检测方法及应用 | |
CN110068645A (zh) | 液质联用检测尿液中环磷酸腺苷的方法 | |
CN114720704B (zh) | 一种测定血清中游离睾酮的试剂盒及方法 | |
CN108760920B (zh) | 一种基于hplc-msms法测定氰霜唑及其代谢物残留量的方法 | |
CN111239303B (zh) | 一种液质联用同时测定人血浆中替格瑞洛及其活性代谢物和内源性腺苷浓度的方法 | |
Aubert et al. | Quantitative analysis of 5‐fluorouracil and 5, 6‐dihydrofluorouracil in plasma by gas chromatography mass spectrometry | |
Lv et al. | On-line galvanic cell generated electrochemiluminescence determination of acyclovir based on the flow injection sampling | |
CN111896643A (zh) | 一种人血浆中儿茶酚胺的液相色谱串联质谱检测方法 | |
Kaale et al. | Gentamicin assay in human serum by solid‐phase extraction and capillary electrophoresis | |
CN115508483A (zh) | 一种快速检测血清样本中甲基丙二酸的lc-ms/ms方法 | |
CN112611814B (zh) | 一种干血片中1,5-脱水葡萄糖醇的测定方法 | |
Liao et al. | Quantitative detection of N7‐(2‐hydroxyethyl) guanine adducts in DNA using high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry | |
CN114371227A (zh) | 血中舒芬太尼及代谢物的超高压液质联用检验方法 | |
CN113030343A (zh) | 一种血浆中吡咯喹啉醌的液相色谱串联质谱检测方法 | |
Uchikura | Fluorometric determination of urinary Vanilmandelic acid and Homovanillic acid by high performance liquid chromatography after electrochemical oxidation | |
CN103512991A (zh) | 尿液中丙烯酰胺巯基尿酸代谢物的自动在线分析方法 | |
CN112710773B (zh) | 一种采用离子色谱法同时检测磷霉素及其二醇物的方法 | |
CN103808836B (zh) | 一种尿液中3-烷化腺嘌呤dna加合物的测定方法 | |
CN108254467B (zh) | 一种肺炎多糖疫苗水解液中戊糖、己糖、氨基糖和糖醛酸的含量测定方法 | |
CN116858978B (zh) | 一种同时检测门冬胰岛素和德谷胰岛素的方法及其血浆样品处理方法 | |
CN114563504B (zh) | 一种测定血浆中游离醛固酮含量的方法及试剂盒 | |
CN114924016B (zh) | 同时检测硫酸化及未硫酸化胃泌素g17的方法及其检测试剂盒 | |
CN106383191B (zh) | 一种尿液中d-泛酸含量的液相色谱串联质谱测定方法 | |
CN116465989A (zh) | 一种阳离子改性剂中2,3-二羟基丙基-三甲基氯化铵的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221013 Address after: Building 30, Biomedical Industrial Park, No. 218, Sangtian Street, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone, Jiangsu Province, 215000 Patentee after: SUZHOU YAOMING ZEKANG BIOTECHNOLOGY CO.,LTD. Patentee after: SHANGHAI YOUMING AUTOMETRIC MEDICAL TECHNOLOGY Co.,Ltd. Patentee after: Shanghai Yaoming aozhe medical laboratory Co.,Ltd. Address before: No. 211, Fute North Road, pilot Free Trade Zone, Pudong New Area, Shanghai 200131 Patentee before: SHANGHAI YOUMING AUTOMETRIC MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |